CRISPR THERAPEUTICS AG (CRSP)

57.72 -2.78% (-1.65)

Over 1M: +20.3%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

50 55 60
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 824K Q3 '21 — Operating Cash Flow: -81.3M Q3 '21 — Free Cash Flow: -118.4M Q3 '21 — Net Income: -127.2M Q4 '21 — Revenue: 12.9M Q4 '21 — Operating Cash Flow: -86M Q4 '21 — Free Cash Flow: -95.2M Q4 '21 — Net Income: -141.2M Q1 '22 — Revenue: 940K Q1 '22 — Operating Cash Flow: -135.2M Q1 '22 — Free Cash Flow: -150.6M Q1 '22 — Net Income: -179.2M Q2 '22 — Revenue: 158K Q2 '22 — Operating Cash Flow: -142M Q2 '22 — Free Cash Flow: -151.6M Q2 '22 — Net Income: -185.8M Q3 '22 — Revenue: 94K Q3 '22 — Operating Cash Flow: -105.2M Q3 '22 — Free Cash Flow: -111.2M Q3 '22 — Net Income: -174.5M Q4 '22 — Revenue: 6K Q4 '22 — Operating Cash Flow: -113.3M Q4 '22 — Free Cash Flow: -119.5M Q4 '22 — Net Income: -110.6M Q1 '23 — Revenue: 100M Q1 '23 — Operating Cash Flow: 8.8M Q1 '23 — Free Cash Flow: 5.7M Q1 '23 — Net Income: -53.1M Q2 '23 — Revenue: 70M Q2 '23 — Operating Cash Flow: -133.2M Q2 '23 — Free Cash Flow: -136.8M Q2 '23 — Net Income: -77.7M Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -39.9M Q3 '23 — Free Cash Flow: -42M Q3 '23 — Net Income: -112.2M Q4 '23 — Revenue: 201.2M Q4 '23 — Operating Cash Flow: -96.1M Q4 '23 — Free Cash Flow: -96.8M Q4 '23 — Net Income: 89.3M Q1 '24 — Revenue: 504K Q1 '24 — Operating Cash Flow: 109.8M Q1 '24 — Free Cash Flow: 109M Q1 '24 — Net Income: -116.6M Q2 '24 — Revenue: 517K Q2 '24 — Operating Cash Flow: -95.6M Q2 '24 — Free Cash Flow: -96.3M Q2 '24 — Net Income: -126.4M Q3 '24 — Revenue: 602K Q3 '24 — Operating Cash Flow: -106.9M Q3 '24 — Free Cash Flow: -107.1M Q3 '24 — Net Income: -85.9M Q4 '24 — Revenue: 35.7M Q4 '24 — Operating Cash Flow: -50M Q4 '24 — Free Cash Flow: -50.3M Q4 '24 — Net Income: -37.3M Q1 '25 — Revenue: 865K Q1 '25 — Operating Cash Flow: -53.9M Q1 '25 — Free Cash Flow: -54.2M Q1 '25 — Net Income: -136M Q2 '25 — Revenue: 892K Q2 '25 — Operating Cash Flow: -113.9M Q2 '25 — Free Cash Flow: -114M Q2 '25 — Net Income: -208.5M Q3 '25 — Revenue: 889K Q3 '25 — Operating Cash Flow: -84.6M Q3 '25 — Free Cash Flow: -84.7M Q3 '25 — Net Income: -106.4M Q4 '25 — Revenue: 864K Q4 '25 — Operating Cash Flow: -92.6M Q4 '25 — Free Cash Flow: -93.1M Q4 '25 — Net Income: -130.6M Q1 '26 — Revenue: 1.5M Q1 '26 — Operating Cash Flow: -108.9M Q1 '26 — Free Cash Flow: -109.4M Q1 '26 — Net Income: -122.9M Q2 '26 — Revenue: 10.2M Q2 '26 — Operating Cash Flow: -83.5M Q2 '26 — Free Cash Flow: -84.1M Q2 '26 — Net Income: -91.2M -180M -90M 0 90M 180M 270M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 510.2%
Accruals -3.1%
Asset turnover 0.0051×
ROA -17.0%
ROCE -21.2%
ROE -25.8%
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 1.1×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
Current ratio 20.1×
ND/EBITDA —
Interest cover -137.8×
Cash / Debt 4.0×
Debt payback 0.0 yr
Quick ratio 17.8×
Cash runway 4.8 yr
Debt / Eq 0.34×
F-score 1.3 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales CAGR 4Y -75.1%
Sales/sh Y/Y -67.0%
Sales Q/Q +1041.4%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.